Physician profile
Daniel Cameron Reece
NPI 1306229893
$1,929.54
in general payments reported to CMS, 2019-2025
11 companies · $22.90 in 2025
The $22.90 reported for 2025 was less than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $654 · 2020: $14.41 · 2021: $76.21 · 2022: $283 · 2023: $331 · 2024: $548 · 2025: $22.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $901.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nobel Biocare USA | $638.56 | 2019-2023 | Nobelactive |
| Stryker Corporation | $315.69 | 2019-2023 | Na, Patient-Fitted Tmj Reconstructive Prosthesis System, Vsp System, Vsp Cranial |
| Geistlich Pharma, North America, INC. | $294.00 | 2024 | Geistlich Bio-Gide |
| Southern Anesthesia & Surgical, INC (Dba Ace Southern) | $292.06 | 2019-2023 | |
| Straumann USA LLC | $124.90 | 2022-2024 | |
| Biohorizons Implant Systems INC. | $77.62 | 2019 | |
| Envista Holdings Corporation | $72.85 | 2024 | Instrumentarium Op300 |
| Dentsply Sirona INC | $62.94 | 2024 | Astra Tech Implant System |
| Kls-Martin L.P. | $22.90 | 2025 | |
| USA Angelalign Technology Corp | $14.11 | 2023 | |
| Zimvie INC. | $13.91 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Reece listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.